Header cover image
  • Investing Ideas
  • /
  • Slovenian Pharmaceuticals & Biotech Potentially Undervalued Companies

Slovenian Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

1

0 new

Companies with a Value score of at least 3, ordered by Value score

1 companies

Krka d. d

Market Cap: €6.7b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

KRKG

€221.00

7D

1.4%

1Y

62.5%